Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.

ABSTRACT:

Introduction

In spite of chlamydia screening recommendations, U.S. testing coverage continues to be low. This study explored the cost-effectiveness of a patient-directed, universal, opportunistic Opt-Out Testing strategy (based on insurance coverage, healthcare utilization, and test acceptance probabilities) for all women aged 15-24 years compared with current Risk-Based Screening (30% coverage) from a societal perspective.

Methods

Based on insurance coverage (80%); healthcare utilization (83%); and test acceptance (75%), the proposed Opt-Out Testing strategy would have an expected annual testing coverage of approximately 50% for sexually active women aged 15-24 years. A basic compartmental heterosexual transmission model was developed to account for population-level transmi

SUBMITTER: Owusu-Edusei K 

PROVIDER: S-EPMC6785744 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature